Round Table Services’s Travere Therapeutics TVTX Stock Holding History

Round Table Services’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-35,000	Closed	-$679K	–	122
2017 Q2	$679K	Sell	35,000 -15,000	-30%	-$272K	0.25%	42
2017 Q1	$923K	Sell	50,000 -10,000	-17%	-$196K	0.33%	32
2016 Q4	$1.14M	Hold	60,000	–	–	0.46%	30
2016 Q3	$1.34M	Hold	60,000	–	–	0.8%	22
2016 Q2	$1.07M	Hold	60,000	–	–	0.6%	33
2016 Q1	$820K	Hold	60,000	–	–	0.51%	38
2015 Q4	$1.16M	Hold	60,000	–	–	0.84%	30
2015 Q3	$1.22M	Hold	60,000	–	–	0.89%	31
2015 Q2	$1.99M	Hold	60,000	–	–	1.55%	20
2015 Q1	$1.44M	Sell	60,000 -215,852	-78%	-$3.29M	1.13%	24
2014 Q4	$3.38M	Buy	275,852 +220,502	+398%	+$2.28M	2.66%	14
2014 Q3	$499K	Buy	+55,350	New	+$651K	0.42%	33

Other funds holding TVTX

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Round Table Services's TVTX Position: Q3 2017 in Review

Round Table Services sold out of Travere Therapeutics (TVTX) in Q3 2017, closing a stake of 35,000 shares — an estimated $679K sold.

Round Table Services first reported a position in TVTX in Q3 2014 and held it in 12 quarters. The position peaked at $3.38M in Q4 2014. 113 funds tracked by Wall St. Rank hold TVTX as of Q3 2017.

Round Table Services reported no remaining Travere Therapeutics position as of Q3 2017 after selling out during the quarter.
Round Table Services sold 35,000 Travere Therapeutics shares in Q3 2017, an estimated $679K.
Round Table Services first reported a position in Travere Therapeutics in Q3 2014 and held it in 12 quarters.
Round Table Services's Travere Therapeutics position peaked at $3.38M in Q4 2014.
113 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2017.

Based on Round Table Services's 13F filing for Q3 2017, filed 19 Oct 2017.